The protective role of short-chain fatty acids acting as signal molecules in chemotherapy- or radiation-induced intestinal inflammation.

Evidence supporting the therapeutic potential of SCFAs for the management of chemotherapy- or radiation-induced intestinal inflammation and microbial dysbiosis is reviewed and the mechanisms of SCFA production and its effects on intestinal mucositis are summarized.